Navigation Links
Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data,Selected for Scientific Highlights Program at the American Academy,of Neurology Meeting

ics disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About Acorda Therapeutics

Acorda Therapeutics is a biotechnology company developing therapies for SCI, MS and related nervous system disorders. The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. For full prescribing information, please go to www.zanaflexcapsules.com. Acorda's lead clinical stage product, Fampridine-SR, recently completed a Phase 3 study in people with MS. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.

Contact

Acorda Therapeutics
Erica Wishner, 914-347-4300 ext. 162
ewishner@acorda.com


'"/>




Page: 1 2

Related medicine technology :

1. Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting
2. Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
3. Acorda Therapeutics to Host Analyst and Investor Reception
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23

Post Your Comments:
(Date:11/9/2009)...WOOD, Ill., Nov. 9 Land...personal and environmental radiation monitoring se...isitions in accordance with its long-term strategi...e acquisitions of Global Physics Solutions, Inc. (... Saxelby, President and CEO of Landauer. "These ac...
(Date:11/9/2009)...NEW YORK, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Am..., ("the Company" or "AOBO"), a pharmaceutical,comp...lopment, manufacture and,commercialization of a br...TC"),products, today announced that it plans to re...ay, November 16, 2009, after the market closes. ,...
(Date:11/9/2009)...TON, Nov. 9 Patent attorneys Cher..., Ph.D., J. D., will showcase Stipkala LLC at the ..., which will be held at the Institute of Molecular...Conference provides a platform for cutting-edge co... investors, and will feature keynote addresses and...
Breaking Medicine Technology:Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Precision Antibody Wins Contract to Develop Gold Standard Antibodies as Part of National Cancer Institutes Clinical Proteomics Technologies for Cancer 14606 1Precision Antibody Wins Contract to Develop Gold Standard Antibodies as Part of National Cancer Institutes Clinical Proteomics Technologies for Cancer 14606 2Precision Antibody Wins Contract to Develop Gold Standard Antibodies as Part of National Cancer Institutes Clinical Proteomics Technologies for Cancer 14606 3E CigaretteDirect com Endorsed By Prominent Doctor 5736 1E CigaretteDirect com Endorsed By Prominent Doctor 5736 2NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 1NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 2NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 3
...ticals,Inc., a privately held biopharmaceutical co...d today that the U.S. Food and Drug,Administration...anted A-001,orphan drug status for the prevention ...ll disease., A-001 is currently being evaluated f...al in the United States called IMPACTS (Investigat...
...n,(Nasdaq: DRRX ) announced today positive result...DURECT,s proprietary investigational transdermal p...m post-herpetic neuralgia,ELADUR showed improved p...uous treatment period. In addition, ELADUR appeare...h ELADUR and placebo exhibited similar,safety prof...
Other Medicine Technology:Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 2Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 3DURECT Announces Positive ELADUR(TM) Phase IIa Study Results 2DURECT Announces Positive ELADUR(TM) Phase IIa Study Results 3
(Date:11/9/2009)...orrow may be too late when it comes to preventing ...PS Club, Inc. (Take Off Pounds Sensibly), the nonp... (Vocus) November 9, 2009 -- Tomor... improving a diabetes condition, according to TOPS...fit weight-loss support organization., , ,Diabetes...
(Date:11/9/2009)...ive Cancer Network (NCCN) has posted a draft white...adigm for near-term comparative effectiveness clin...ument introduces the NCCN Comparative Therapeutic ...mpares the risk-versus-benefit of different treatm...ice Guidelines in Oncology(TM). The paper will be ...
(Date:11/9/2009)...2010 National Ambassador ,, WHITE PLAINS, N.Y...n of Weston, Fla., was born so early and with so m...ay whether he would survive -- or if he would ever...s named March of Dimes 2010 National Ambassador. ...first minutes of motherhood and I was completely d...
(Date:11/9/2009)...swire-FirstCall/ -- The award-winning documentary ...debut on the Sundance Channel on World Diabetes Da...ted by Academy Award® nominee Edward Lachman,...pe 1 diabetes amid the verdant mountains and swarm...tries. The children are supported with life-saving...
(Date:11/9/2009)...swire/ -- Phoenix House , the nation,s leadin...prevention program, announced today its appointmen...ionally recognized leader in substance abuse treat...ctive January 1, 2010. ,, "Dr. Deni Carise is...t research and her work has resulted in a signific...
Breaking Medicine News(10 mins):Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3
...ood physical or sexual abuse are more likely to us...female partner when they are adolescents and young... that put men at risk for committing sexual coerci...an men who were not abused, said Erin Casey, a Uni...
...ickey, MD,president of the Texas A&M Health Scienc...r the Texas A&M University System, has been named ... of Academic Health Centers., A former dean and c...nding program director of the Family Practice,Resi...
...ns, Educates about Dangers of Alcohol, HARRISBURG...l districts have been named by the Pennsylvania,Li...hol Awareness Poster,Contest., The awards recogni...ed in conjunction with the state departments,of He...
....3 million,children a year, mostly from low- to mi... to pay for preventive or other medical needs, eve... according to a new study supported,by HHS, Agency...ished in the Oct. 22/29, 2008, online issue of JAM...
...oral healthcare portfolio -, LONDON, Oct. 21 Gla...ounced today that it has reached an agreement with...e leading Dry Mouth brand,Biotene(R) for $170 mill...2009., "The acquisition of Biotene extends our po...
...ore than ever, employers,are looking for ways to c...tuous times call for stabilizing influences, and w...oneStart Wellness co-founder. "Now is not,the time...ts of a sustainable workplace wellness program.", ...
Other Medicine News:Health News:Child abuse increases risk for later sexually coercive behavior in some men 2Health News:Child abuse increases risk for later sexually coercive behavior in some men 3Health News:Association of Academic Health Centers Names Texas A&M's Dr. Nancy W. Dickey Chair of the Board of Directors 2Health News:PLCB Honors Winners of 2008 Alcohol Awareness Poster Contest 2Health News:PLCB Honors Winners of 2008 Alcohol Awareness Poster Contest 3Health News:PLCB Honors Winners of 2008 Alcohol Awareness Poster Contest 4Health News:More Than 2 Million Children With Insured Parents Are Uninsured; Most Are Low or Middle Income 2Health News:More Than 2 Million Children With Insured Parents Are Uninsured; Most Are Low or Middle Income 3Health News:GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene 2Health News:Even During Financial Crisis Investing in Wellness is Good Business 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: